Dai-ichi Life Insurance Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.82M Buy
242,836
+19,771
+9% +$526K 0.2% 115
2025
Q4
$5.55M Sell
223,065
-4,161
-2% -$105K 0.14% 154
2025
Q3
$5.79M Hold
227,226
0.15% 151
2025
Q2
$5.51M Buy
227,226
+23,402
+11% +$546K 0.15% 141
2025
Q1
$5.16M Hold
203,824
0.15% 147
2024
Q4
$5.41M Sell
203,824
-40,000
-16% -$1.08M 0.15% 152
2024
Q3
$7.06M Buy
243,824
+60,000
+33% +$1.75M 0.18% 121
2024
Q2
$5.14M Sell
183,824
-12,255
-6% -$337K 0.13% 171
2024
Q1
$5.44M Sell
196,079
-3,032
-2% -$84.1K 0.12% 157
2023
Q4
$5.73M Sell
199,111
-238,731
-55% -$7.22M 0.12% 162
2023
Q3
$14.5M Sell
437,842
-868,995
-66% -$30.7M 0.32% 72
2023
Q2
$47.9M Buy
1,306,837
+651,477
+99% +$25.4M 1% 17
2023
Q1
$26.7M Buy
655,360
+38,458
+6% +$1.66M 0.59% 34
2022
Q4
$31.6M Buy
616,902
+139,450
+29% +$6.69M 0.73% 26
2022
Q3
$20.9M Sell
477,452
-25,372
-5% -$1.23M 0.51% 41
2022
Q2
$26.4M Sell
502,824
-159,210
-24% -$8.11M 0.59% 33
2022
Q1
$34.3M Buy
662,034
+118,075
+22% +$6.13M 0.55% 34
2021
Q4
$32.1M Buy
543,959
+53,765
+11% +$2.66M 0.41% 45
2021
Q3
$21.1M Buy
490,194
+28,162
+6% +$1.25M 0.27% 70
2021
Q2
$18.1M Buy
462,032
+116,644
+34% +$4.54M 0.23% 88
2021
Q1
$12.5M Sell
345,388
-75,742
-18% -$2.69M 0.17% 99
2020
Q4
$15.5M Sell
421,130
-186,775
-31% -$6.85M 0.22% 78
2020
Q3
$21.2M Buy
607,905
+7,248
+1% +$254K 0.38% 41
2020
Q2
$18.6M Sell
600,657
-9,533
-2% -$324K 0.43% 38
2020
Q1
$18.9M Sell
610,190
-165,906
-21% -$5.65M 0.73% 28
2019
Q4
$28.9M Sell
776,096
-146,719
-16% -$5.23M 0.65% 32
2019
Q3
$31.5M Buy
922,815
+93,285
+11% +$3.39M 0.75% 27
2019
Q2
$34.1M Buy
829,530
+33,729
+4% +$1.34M 0.83% 23
2019
Q1
$32.1M Sell
795,801
-27,908
-3% -$1.12M 0.79% 24
2018
Q4
$34.1M Sell
823,709
-5,946
-0.7% -$247K 0.93% 18
2018
Q3
$34.7M Buy
829,655
+137,458
+20% +$5.29M 0.75% 23
2018
Q2
$23.8M Sell
692,197
-74,736
-10% -$2.55M 0.57% 35
2018
Q1
$25.8M Sell
766,933
-39,759
-5% -$1.37M 0.53% 37
2017
Q4
$27.7M Sell
806,692
-19,156
-2% -$653K 0.54% 36
2017
Q3
$28M Sell
825,848
-502
-0.1% -$16.1K 0.59% 35
2017
Q2
$26.3M Sell
826,350
-118,890
-13% -$3.75M 0.59% 34
2017
Q1
$30.7M Sell
945,240
-3,820
-0.4% -$120K 0.83% 23
2016
Q4
$29.2M Buy
+949,060
New +$29M 0.87% 22

Other funds holding PFE

Dai-ichi Life Insurance Company's PFE Position: Q1 2026 in Review

Dai-ichi Life Insurance Company increased its Pfizer (PFE) stake by 8.9% in Q1 2026, buying an estimated $526K and bringing the position to 242,836 shares worth $6.82M. The position accounts for 0.2% of the portfolio, ranked #115.

Dai-ichi Life Insurance Company first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $47.9M in Q2 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Dai-ichi Life Insurance Company held 242,836 shares of Pfizer worth $6.82M as of Q1 2026.
  • Dai-ichi Life Insurance Company bought 19,771 Pfizer shares in Q1 2026, an estimated $526K.
  • Pfizer made up 0.2% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #115 holding.
  • Dai-ichi Life Insurance Company first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
  • Dai-ichi Life Insurance Company's Pfizer position peaked at $47.9M in Q2 2023.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.